Direct-to-consumer (D2C) ayurvedic brand Kapiva is nearing a deal to raise Rs 300-330 crore (~$40 million) in an internal funding round. OrbiMed, an existing investor, is expected to lead the round, with participation from Fireside Ventures, Vertex Ventures, and others. Founded in 2016, Kapiva offers ayurvedic products like juices, teas, and oils for health issues such as hair fall and diabetes. The brand’s valuation is estimated to rise to $130-150 million. Kapiva’s revenue grew to Rs 115 crore in FY23, though losses widened to Rs 65 crore.